BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 34858403)

  • 1. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
    Zhao Y; Yin L; Patel J; Tang L; Huang Y
    J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
    Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
    PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory biomarkers and prognosis in Covid-19, where do we stand?
    Israni A; Goulden CJ; Harky A
    Rev Med Virol; 2021 Nov; 31(6):e2296. PubMed ID: 34516018
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.
    Avila-Nava A; Cortes-Telles A; Torres-Erazo D; López-Romero S; Chim Aké R; Gutiérrez Solis AL
    Cytokine; 2021 Jul; 143():155543. PubMed ID: 33896708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of COVID-19: Changes in laboratory parameters.
    Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D
    Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?
    Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Saussez S; Policicchio D; Boccaletti R; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
    J Laryngol Otol; 2021 Aug; 135(8):723-728. PubMed ID: 34184623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
    Liu Y; Chen D; Hou J; Li H; Cao D; Guo M; Ling Y; Gao M; Zhou Y; Wan Y; Zhu Z
    Cytokine; 2021 Feb; 138():155365. PubMed ID: 33246770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory biomarkers associated with COVID-19 severity and management.
    Keddie S; Ziff O; Chou MKL; Taylor RL; Heslegrave A; Garr E; Lakdawala N; Church A; Ludwig D; Manson J; Scully M; Nastouli E; Chapman MD; Hart M; Lunn MP
    Clin Immunol; 2020 Dec; 221():108614. PubMed ID: 33153974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of type III interferons in patients with severe COVID-19.
    Fukuda Y; Homma T; Inoue H; Onitsuka C; Ikeda H; Goto Y; Sato Y; Kimura T; Hirai K; Ohta S; Yamamoto M; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Med Virol; 2021 Jul; 93(7):4559-4563. PubMed ID: 33811680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing Correlation of Clinical Severity of COVID-19 with Other Biochemical Parameters: A Retrospective Study from Pakistan.
    Hassan Shah SST; Naeem I; Wahid B
    Tohoku J Exp Med; 2021 Dec; 255(4):315-323. PubMed ID: 34911879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
    Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
    PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019.
    Santotoribio JD; Nuñez-Jurado D; Lepe-Balsalobre E
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.